Novartis AG (NYSE:NVS)
| 83.31 BATS BZX Real-Time Price As of 12:08pm ET |  -0.12 / -0.14%Today’s Change | 74.09 Today|||52-Week Range 94.26 | -8.17% Year-to-Date |
Latest NVS News | Press Releases
Today’s Trading
| Previous close | 83.43 |
| Today’s open | 83.66 |
| Day’s range | 83.17 - 83.76 |
| Volume | 854,877 |
| Average volume (3 months) | 2,028,175 |
| Market cap | $175.5B |
Data as of 12:08pm ET, 03/21/2023
Growth & Valuation
| Earnings growth (last year) | -70.23% |
| Earnings growth (this year) | +7.84% |
| Earnings growth (next 5 years) | +5.68% |
| Revenue growth (last year) | -2.09% |
| P/E ratio | 26.3 |
| Price/Sales | 3.94 |
| Price/Book | 2.96 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| AZNAstraZeneca | -0.24 | -0.37% |
| BMYBristol-Myers Squibb | +0.15 | +0.22% |
| PFEPfizer | -0.26 | -0.64% |
| SNYSanofi | +0.56 | +1.17% |
Data as of 12:08pm ET, 03/21/2023
Financials
| Next reporting date | April 25, 2023 |
| EPS forecast (this quarter) | $1.53 |
| Annual revenue (last year) | $50.5B |
| Annual profit (last year) | $7.0B |
| Net profit margin | 13.76% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Basel, Basel-stadt (basle Town) |
Forecasts
